Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
 
Authors :  J. H. Bae, K. P. Ravindranathan, V. Mandiyan, A. R. Ekkati, J. Schlessinger, W. L. Jorgensen
Date :  09 Sep 09  (Deposition) - 23 Feb 10  (Release) - 02 Mar 10  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.20
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A,B  (1x)
Biol. Unit 2:  A,B  (1x)
Keywords :  Fibroblast Growth Factor, Receptor Tyrosine Kinase, Inhibitor, Thienyl Nicotinic Acid, Alternative Splicing, Atp-Binding, Chromosomal Rearrangement, Craniosynostosis, Disease Mutation, Disulfide Bond, Dwarfism, Glycoprotein, Heparin-Binding, Hypogonadotropic Hypogonadism, Immunoglobulin Domain, Kallmann Syndrome, Kinase, Membrane, Nucleotide-Binding, Phosphoprotein, Polymorphism, Receptor, Transferase, Transmembrane, Tyrosine-Protein Kinase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  K. P. Ravindranathan, V. Mandiyan, A. R. Ekkati, J. H. Bae, J. Schlessinger, W. L. Jorgensen
Discovery Of Novel Fibroblast Growth Factor Receptor 1 Kinase Inhibitors By Structure-Based Virtual Screening
J. Med. Chem. V. 53 1662 2010
PubMed-ID: 20121196  |  Reference-DOI: 10.1021/JM901386E

(-) Compounds

Molecule 1 - BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1
    ChainsA, B
    EC Number2.7.10.1
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System PlasmidPET-N6
    Expression System StrainBL21(CODON+)
    Expression System Taxid562
    Expression System Vector TypePLASMID
    GeneFGFR1, FGFBR, FLG, FLT2
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymFGFR-1, BFGF-R, FMS-LIKE TYROSINE KINASE 2, C-FGR

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (1x)AB
Biological Unit 2 (1x)AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 4)

Asymmetric Unit (2, 4)
No.NameCountTypeFull Name
1PO42Ligand/IonPHOSPHATE ION
2VM12Ligand/Ion5-(2-THIENYL)NICOTINIC ACID
Biological Unit 1 (2, 4)
No.NameCountTypeFull Name
1PO42Ligand/IonPHOSPHATE ION
2VM12Ligand/Ion5-(2-THIENYL)NICOTINIC ACID
Biological Unit 2 (2, 4)
No.NameCountTypeFull Name
1PO42Ligand/IonPHOSPHATE ION
2VM12Ligand/Ion5-(2-THIENYL)NICOTINIC ACID

(-) Sites  (4, 4)

Asymmetric Unit (4, 4)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREHOH A:132 , LEU A:484 , ILE A:545 , VAL A:561 , GLU A:562 , TYR A:563 , ALA A:564 , LEU A:630BINDING SITE FOR RESIDUE VM1 A 801
2AC2SOFTWAREHOH A:37 , HOH A:144 , ARG A:570 , ARG A:627 , THR A:657 , ASN A:659 , ARG A:661BINDING SITE FOR RESIDUE PO4 A 1
3AC3SOFTWARELEU B:484 , VAL B:492 , GLU B:562 , TYR B:563 , ALA B:564 , LEU B:630BINDING SITE FOR RESIDUE VM1 B 801
4AC4SOFTWAREHOH B:5 , HOH B:143 , ARG B:570 , ARG B:627 , THR B:657 , ASN B:659 , ARG B:661BINDING SITE FOR RESIDUE PO4 B 2

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 3JS2)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 3JS2)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (33, 66)

Asymmetric Unit (33, 66)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_069292R470LFGFR1_HUMANDisease (HH2)121909637A/BR470L
02UniProtVAR_069956P483TFGFR1_HUMANDisease (HH2)397515444A/BP483T
03UniProtVAR_070853G490RFGFR1_HUMANDisease (HRTFDS)869025670A/BG490R
04UniProtVAR_030995A520TFGFR1_HUMANDisease (HH2)749758370A/BA520T
05UniProtVAR_030996I538VFGFR1_HUMANDisease (HH2)  ---A/BI538V
06UniProtVAR_075853N546KFGFR1_HUMANDisease (ECCL)  ---A/BN546K
07UniProtVAR_075854V561MFGFR1_HUMANPolymorphism  ---A/BV561M
08UniProtVAR_017889V607MFGFR1_HUMANDisease (HH2)121909629A/BV607M
09UniProtVAR_069293K618NFGFR1_HUMANDisease (HH2)  ---A/BK618N
10UniProtVAR_030997H621RFGFR1_HUMANDisease (HH2)  ---A/BH621R
11UniProtVAR_030998R622GFGFR1_HUMANDisease (HH2)  ---A/BR622G
12UniProtVAR_030999R622QFGFR1_HUMANDisease (HH2)  ---A/BR622Q
13UniProtVAR_070854D623YFGFR1_HUMANDisease (HRTFDS)398122946A/BD623Y
14UniProtVAR_071460R627TFGFR1_HUMANDisease (HRTFDS)869025671A/BR627T
15UniProtVAR_070855N628KFGFR1_HUMANDisease (HRTFDS)869025672A/BN628K
16UniProtVAR_075855K656EFGFR1_HUMANDisease (ECCL)869320694A/BK656E
17UniProtVAR_042203V664LFGFR1_HUMANUnclassified  ---A/BV664L
18UniProtVAR_017890W666RFGFR1_HUMANDisease (HH2)  ---A/BW666R
19UniProtVAR_069957E670KFGFR1_HUMANDisease (HH2)397515446A/BE670K
20UniProtVAR_069294A671PFGFR1_HUMANDisease (HH2)  ---A/BA671P
21UniProtVAR_031000S685FFGFR1_HUMANDisease (HH2)  ---A/BS685F
22UniProtVAR_031001G687RFGFR1_HUMANDisease (HH2)727505376A/BG687R
23UniProtVAR_069958E692GFGFR1_HUMANDisease (HH2)397515445A/BE692G
24UniProtVAR_031002I693FFGFR1_HUMANDisease (HH2)  ---A/BI693F
25UniProtVAR_031003G703RFGFR1_HUMANDisease (HH2)  ---A/BG703R
26UniProtVAR_031004G703SFGFR1_HUMANDisease (HH2)768957161A/BG703S
27UniProtVAR_017891M719RFGFR1_HUMANDisease (HH2)  ---A/BM719R
28UniProtVAR_074014M719VFGFR1_HUMANUnclassified (HH2)  ---A/BM719V
29UniProtVAR_031005P722HFGFR1_HUMANDisease (HH2)267606805A/BP722H
30UniProtVAR_031006P722SFGFR1_HUMANDisease (HH2)121909642A/BP722S
31UniProtVAR_031007N724KFGFR1_HUMANDisease (HH2)267606806A/BN724K
32UniProtVAR_070856C725YFGFR1_HUMANDisease (HRTFDS)398122945A/BC725Y
33UniProtVAR_031008P745SFGFR1_HUMANDisease (HH2)  ---A/BP745S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (33, 66)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_069292R470LFGFR1_HUMANDisease (HH2)121909637A/BR470L
02UniProtVAR_069956P483TFGFR1_HUMANDisease (HH2)397515444A/BP483T
03UniProtVAR_070853G490RFGFR1_HUMANDisease (HRTFDS)869025670A/BG490R
04UniProtVAR_030995A520TFGFR1_HUMANDisease (HH2)749758370A/BA520T
05UniProtVAR_030996I538VFGFR1_HUMANDisease (HH2)  ---A/BI538V
06UniProtVAR_075853N546KFGFR1_HUMANDisease (ECCL)  ---A/BN546K
07UniProtVAR_075854V561MFGFR1_HUMANPolymorphism  ---A/BV561M
08UniProtVAR_017889V607MFGFR1_HUMANDisease (HH2)121909629A/BV607M
09UniProtVAR_069293K618NFGFR1_HUMANDisease (HH2)  ---A/BK618N
10UniProtVAR_030997H621RFGFR1_HUMANDisease (HH2)  ---A/BH621R
11UniProtVAR_030998R622GFGFR1_HUMANDisease (HH2)  ---A/BR622G
12UniProtVAR_030999R622QFGFR1_HUMANDisease (HH2)  ---A/BR622Q
13UniProtVAR_070854D623YFGFR1_HUMANDisease (HRTFDS)398122946A/BD623Y
14UniProtVAR_071460R627TFGFR1_HUMANDisease (HRTFDS)869025671A/BR627T
15UniProtVAR_070855N628KFGFR1_HUMANDisease (HRTFDS)869025672A/BN628K
16UniProtVAR_075855K656EFGFR1_HUMANDisease (ECCL)869320694A/BK656E
17UniProtVAR_042203V664LFGFR1_HUMANUnclassified  ---A/BV664L
18UniProtVAR_017890W666RFGFR1_HUMANDisease (HH2)  ---A/BW666R
19UniProtVAR_069957E670KFGFR1_HUMANDisease (HH2)397515446A/BE670K
20UniProtVAR_069294A671PFGFR1_HUMANDisease (HH2)  ---A/BA671P
21UniProtVAR_031000S685FFGFR1_HUMANDisease (HH2)  ---A/BS685F
22UniProtVAR_031001G687RFGFR1_HUMANDisease (HH2)727505376A/BG687R
23UniProtVAR_069958E692GFGFR1_HUMANDisease (HH2)397515445A/BE692G
24UniProtVAR_031002I693FFGFR1_HUMANDisease (HH2)  ---A/BI693F
25UniProtVAR_031003G703RFGFR1_HUMANDisease (HH2)  ---A/BG703R
26UniProtVAR_031004G703SFGFR1_HUMANDisease (HH2)768957161A/BG703S
27UniProtVAR_017891M719RFGFR1_HUMANDisease (HH2)  ---A/BM719R
28UniProtVAR_074014M719VFGFR1_HUMANUnclassified (HH2)  ---A/BM719V
29UniProtVAR_031005P722HFGFR1_HUMANDisease (HH2)267606805A/BP722H
30UniProtVAR_031006P722SFGFR1_HUMANDisease (HH2)121909642A/BP722S
31UniProtVAR_031007N724KFGFR1_HUMANDisease (HH2)267606806A/BN724K
32UniProtVAR_070856C725YFGFR1_HUMANDisease (HRTFDS)398122945A/BC725Y
33UniProtVAR_031008P745SFGFR1_HUMANDisease (HH2)  ---A/BP745S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (33, 66)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_069292R470LFGFR1_HUMANDisease (HH2)121909637A/BR470L
02UniProtVAR_069956P483TFGFR1_HUMANDisease (HH2)397515444A/BP483T
03UniProtVAR_070853G490RFGFR1_HUMANDisease (HRTFDS)869025670A/BG490R
04UniProtVAR_030995A520TFGFR1_HUMANDisease (HH2)749758370A/BA520T
05UniProtVAR_030996I538VFGFR1_HUMANDisease (HH2)  ---A/BI538V
06UniProtVAR_075853N546KFGFR1_HUMANDisease (ECCL)  ---A/BN546K
07UniProtVAR_075854V561MFGFR1_HUMANPolymorphism  ---A/BV561M
08UniProtVAR_017889V607MFGFR1_HUMANDisease (HH2)121909629A/BV607M
09UniProtVAR_069293K618NFGFR1_HUMANDisease (HH2)  ---A/BK618N
10UniProtVAR_030997H621RFGFR1_HUMANDisease (HH2)  ---A/BH621R
11UniProtVAR_030998R622GFGFR1_HUMANDisease (HH2)  ---A/BR622G
12UniProtVAR_030999R622QFGFR1_HUMANDisease (HH2)  ---A/BR622Q
13UniProtVAR_070854D623YFGFR1_HUMANDisease (HRTFDS)398122946A/BD623Y
14UniProtVAR_071460R627TFGFR1_HUMANDisease (HRTFDS)869025671A/BR627T
15UniProtVAR_070855N628KFGFR1_HUMANDisease (HRTFDS)869025672A/BN628K
16UniProtVAR_075855K656EFGFR1_HUMANDisease (ECCL)869320694A/BK656E
17UniProtVAR_042203V664LFGFR1_HUMANUnclassified  ---A/BV664L
18UniProtVAR_017890W666RFGFR1_HUMANDisease (HH2)  ---A/BW666R
19UniProtVAR_069957E670KFGFR1_HUMANDisease (HH2)397515446A/BE670K
20UniProtVAR_069294A671PFGFR1_HUMANDisease (HH2)  ---A/BA671P
21UniProtVAR_031000S685FFGFR1_HUMANDisease (HH2)  ---A/BS685F
22UniProtVAR_031001G687RFGFR1_HUMANDisease (HH2)727505376A/BG687R
23UniProtVAR_069958E692GFGFR1_HUMANDisease (HH2)397515445A/BE692G
24UniProtVAR_031002I693FFGFR1_HUMANDisease (HH2)  ---A/BI693F
25UniProtVAR_031003G703RFGFR1_HUMANDisease (HH2)  ---A/BG703R
26UniProtVAR_031004G703SFGFR1_HUMANDisease (HH2)768957161A/BG703S
27UniProtVAR_017891M719RFGFR1_HUMANDisease (HH2)  ---A/BM719R
28UniProtVAR_074014M719VFGFR1_HUMANUnclassified (HH2)  ---A/BM719V
29UniProtVAR_031005P722HFGFR1_HUMANDisease (HH2)267606805A/BP722H
30UniProtVAR_031006P722SFGFR1_HUMANDisease (HH2)121909642A/BP722S
31UniProtVAR_031007N724KFGFR1_HUMANDisease (HH2)267606806A/BN724K
32UniProtVAR_070856C725YFGFR1_HUMANDisease (HRTFDS)398122945A/BC725Y
33UniProtVAR_031008P745SFGFR1_HUMANDisease (HH2)  ---A/BP745S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 4)

Asymmetric Unit (2, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.FGFR1_HUMAN484-514
 
  2A:484-514
B:484-514
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.FGFR1_HUMAN619-631
 
  2A:619-631
B:619-631
Biological Unit 1 (2, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.FGFR1_HUMAN484-514
 
  2A:484-514
B:484-514
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.FGFR1_HUMAN619-631
 
  2A:619-631
B:619-631
Biological Unit 2 (2, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.FGFR1_HUMAN484-514
 
  2A:484-514
B:484-514
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.FGFR1_HUMAN619-631
 
  2A:619-631
B:619-631

(-) Exons   (0, 0)

(no "Exon" information available for 3JS2)

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:295
 aligned with FGFR1_HUMAN | P11362 from UniProtKB/Swiss-Prot  Length:822

    Alignment length:302
                                   473       483       493       503       513       523       533       543       553       563       573       583       593       603       613       623       633       643       653       663       673       683       693       703       713       723       733       743       753       763  
          FGFR1_HUMAN   464 ELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 765
               SCOP domains d3js2a_ A: Fibroblast growth factor receptor 1                                                                                                                                                                                                                                                                 SCOP domains
               CATH domains -3js2A01 A:465-563 Phosphorylase Kinase; domain 1                                                   3js2A02 A:564-759        Transferase(Phosphotransferase) domain 1                                                                                                                                   ------ CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..........hhh.eeeeee........eeeeeee.........eeeeeee......hhhhhhhhhhhhhhhhhhh.......eeeee......eeeee.....hhhhhhhh......-------.......hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee.....eee......................hhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhh.........hhhhhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhhh.... Sec.struct. author
             SAPs(SNPs) (1) ------L------------T------R-----------------------------T-----------------V-------K--------------M---------------------------------------------M----------N--RGY---TK---------------------------E-------L-R---KP-------------F-R----GF---------R---------------R--H-KY-------------------S-------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------Q--------------------------------------------------------------------------------S---------------V--S------------------------------------------- SAPs(SNPs) (2)
                    PROSITE --------------------PROTEIN_KINASE_ATP             --------------------------------------------------------------------------------------------------------PROTEIN_KINAS-------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3js2 A 464 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL-------HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 765
                                   473       483       493       503       513       523       533       543       553       563       573       | -     | 593       603       613       623       633       643       653       663       673       683       693       703       713       723       733       743       753       763  
                                                                                                                                               581     589                                                                                                                                                                                

Chain B from PDB  Type:PROTEIN  Length:291
 aligned with FGFR1_HUMAN | P11362 from UniProtKB/Swiss-Prot  Length:822

    Alignment length:304
                                   468       478       488       498       508       518       528       538       548       558       568       578       588       598       608       618       628       638       648       658       668       678       688       698       708       718       728       738       748       758    
          FGFR1_HUMAN   459 GVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 762
               SCOP domains d3js2b_ B: Fibroblast growth factor receptor 1                                                                                                                                                                                                                                                                   SCOP domains
               CATH domains ------3js2B01 B:465-563 Phosphorylase Kinase; domain 1                                                   3js2B02 B:564-75             9 Transferase(Phosphotransferase) domain 1                                                                                                                             --- CATH domains
           Pfam domains (1) -------------------Pkinase_Tyr-3js2B01 B:478-754                                                                                                                                                                                                                                                        -------- Pfam domains (1)
           Pfam domains (2) -------------------Pkinase_Tyr-3js2B02 B:478-754                                                                                                                                                                                                                                                        -------- Pfam domains (2)
         Sec.struct. author hhhhh..........hhh.eeeeeeeee...eeeeeeeee.........eeeeeeeee....hhhhhhhhhhhhhhhhhhh.......eeeee......eeeee.....hhhhhhhh....-------------...hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee.....eee......................hhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhh.........hhhhhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) -----------L------------T------R-----------------------------T-----------------V-------K--------------M---------------------------------------------M----------N--RGY---TK---------------------------E-------L-R---KP-------------F-R----GF---------R---------------R--H-KY-------------------S----------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------Q--------------------------------------------------------------------------------S---------------V--S---------------------------------------- SAPs(SNPs) (2)
                    PROSITE -------------------------PROTEIN_KINASE_ATP             --------------------------------------------------------------------------------------------------------PROTEIN_KINAS----------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3js2 B 459 GVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP-------------EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 762
                                   468       478       488       498       508       518       528       538       548       558       568       578|        -    |  598       608       618       628       638       648       658       668       678       688       698       708       718       728       738       748       758    
                                                                                                                                                  579           593                                                                                                                                                                         

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 2)

Asymmetric Unit

(-) CATH Domains  (2, 4)

Asymmetric Unit
(-)
Class: Alpha Beta (26913)

(-) Pfam Domains  (1, 2)

Asymmetric Unit
(-)
Clan: PKinase (934)

(-) Gene Ontology  (99, 99)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (FGFR1_HUMAN | P11362)
molecular function
    GO:0016303    1-phosphatidylinositol-3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0005088    Ras guanyl-nucleotide exchange factor activity    Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
    GO:0050839    cell adhesion molecule binding    Interacting selectively and non-covalently with a cell adhesion molecule.
    GO:0017134    fibroblast growth factor binding    Interacting selectively and non-covalently with a fibroblast growth factor.
    GO:0005007    fibroblast growth factor-activated receptor activity    Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0008201    heparin binding    Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0046934    phosphatidylinositol-4,5-bisphosphate 3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0032403    protein complex binding    Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0060117    auditory receptor cell development    The process whose specific outcome is the progression of an auditory receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
    GO:0048514    blood vessel morphogenesis    The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
    GO:0007420    brain development    The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
    GO:0060445    branching involved in salivary gland morphogenesis    The process in which the branching structure of the salivary gland is generated and organized.
    GO:0048469    cell maturation    A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
    GO:0016477    cell migration    The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
    GO:0021954    central nervous system neuron development    The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
    GO:0002062    chondrocyte differentiation    The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
    GO:0043009    chordate embryonic development    The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
    GO:0030326    embryonic limb morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
    GO:0008543    fibroblast growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
    GO:0035607    fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development    The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.
    GO:0048699    generation of neurons    The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons.
    GO:0001701    in utero embryonic development    The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
    GO:0042472    inner ear morphogenesis    The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
    GO:0030324    lung development    The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
    GO:0060484    lung-associated mesenchyme development    The biological process whose specific outcome is the progression of a lung-associated mesenchyme from an initial condition to its mature state. This process begins with the formation of lung-associated mesenchyme and ends with the mature structure. Lung-associated mesenchyme is the tissue made up of loosely connected mesenchymal cells in the lung.
    GO:0048762    mesenchymal cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
    GO:0030901    midbrain development    The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
    GO:0042474    middle ear morphogenesis    The process in which the anatomical structures of the middle ear are generated and organized. The middle ear is the air-filled cavity within the skull of vertebrates that lies between the outer ear and the inner ear. It is linked to the pharynx (and therefore to outside air) via the Eustachian tube and in mammals contains the three ear ossicles, which transmit auditory vibrations from the outer ear (via the tympanum) to the inner ear (via the oval window).
    GO:0021837    motogenic signaling involved in postnatal olfactory bulb interneuron migration    The signaling that results in the stimulation of cell movement in the rostral migratory stream.
    GO:0010629    negative regulation of gene expression    Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0045668    negative regulation of osteoblast differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
    GO:0000122    negative regulation of transcription from RNA polymerase II promoter    Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0001764    neuron migration    The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
    GO:0031175    neuron projection development    The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
    GO:0021769    orbitofrontal cortex development    The progression of the orbitofrontal cortex over time from its initial formation until its mature state. The orbitofrontal cortex is a cerebral cortex region located in the frontal lobe.
    GO:0001759    organ induction    The interaction of two or more cells or tissues that causes them to change their fates and specify the development of an organ.
    GO:0042473    outer ear morphogenesis    The process in which the anatomical structures of the outer ear are generated and organized. The outer ear is the part of the ear external to the tympanum (eardrum). It consists of a tube (the external auditory meatus) that directs sound waves on to the tympanum, and may also include the external pinna, which extends beyond the skull.
    GO:0048339    paraxial mesoderm development    The process whose specific outcome is the progression of the paraxial mesoderm over time, from its formation to the mature structure. The paraxial mesoderm is the mesoderm located bilaterally adjacent to the notochord and neural tube.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0046854    phosphatidylinositol phosphorylation    The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
    GO:0036092    phosphatidylinositol-3-phosphate biosynthetic process    The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
    GO:0048015    phosphatidylinositol-mediated signaling    A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0043406    positive regulation of MAP kinase activity    Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0090080    positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands resulting in an increase in the rate or frequency of a MAPKKK cascade.
    GO:0060045    positive regulation of cardiac muscle cell proliferation    Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
    GO:0045787    positive regulation of cell cycle    Any process that activates or increases the rate or extent of progression through the cell cycle.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:2000546    positive regulation of endothelial cell chemotaxis to fibroblast growth factor    Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
    GO:0002053    positive regulation of mesenchymal cell proliferation    The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
    GO:0045666    positive regulation of neuron differentiation    Any process that activates or increases the frequency, rate or extent of neuron differentiation.
    GO:0010976    positive regulation of neuron projection development    Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
    GO:0014068    positive regulation of phosphatidylinositol 3-kinase signaling    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0010863    positive regulation of phospholipase C activity    Any process that increases the rate of phospholipase C activity.
    GO:0010518    positive regulation of phospholipase activity    Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0060665    regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling    Any process that modulates the rate, frequency, or extent of branching involved in salivary gland morphogenesis as a result of signals being generated by the mesenchyme and received and interpreted by the salivary gland epithelium.
    GO:0045595    regulation of cell differentiation    Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:2001239    regulation of extrinsic apoptotic signaling pathway in absence of ligand    Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
    GO:0010468    regulation of gene expression    Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0048378    regulation of lateral mesodermal cell fate specification    Any process that modulates the frequency, rate or extent of lateral mesoderm cell fate specification.
    GO:0014066    regulation of phosphatidylinositol 3-kinase signaling    Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0051930    regulation of sensory perception of pain    Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
    GO:0072091    regulation of stem cell proliferation    Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
    GO:0006355    regulation of transcription, DNA-templated    Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0007435    salivary gland morphogenesis    The process in which the anatomical structures of the salivary gland are generated and organized.
    GO:0007605    sensory perception of sound    The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.
    GO:0001501    skeletal system development    The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
    GO:0048705    skeletal system morphogenesis    The process in which the anatomical structures of the skeleton are generated and organized.
    GO:0019827    stem cell population maintenance    The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types.
    GO:0006351    transcription, DNA-templated    The cellular synthesis of RNA on a template of DNA.
    GO:0001657    ureteric bud development    The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
    GO:0021847    ventricular zone neuroblast division    The proliferation of neuroblasts in the ventricular zone of the cerebral cortex. The neuronal progenitors of these cells will migrate radially.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031410    cytoplasmic vesicle    A vesicle found in the cytoplasm of a cell.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    PO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    VM1  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 3js2)
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3js2
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FGFR1_HUMAN | P11362
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.10.1
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  147950
    Disease InformationOMIM
  613001
    Disease InformationOMIM
  615465
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FGFR1_HUMAN | P11362
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FGFR1_HUMAN | P113621agw 1cvs 1evt 1fgi 1fgk 1fq9 1xr0 2cr3 2fgi 3c4f 3dpk 3gqi 3gql 3krj 3krl 3kxx 3ky2 3ojv 3rhx 3tt0 4f63 4f64 4f65 4nk9 4nka 4nks 4rwi 4rwj 4rwk 4rwl 4uwb 4uwc 4uwy 4v01 4v04 4v05 4wun 4zsa 5a46 5a4c 5am6 5am7 5b7v 5ew8 5flf 5uq0 5ur1 5vnd

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 3JS2)